nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—DRD2—Gilles de la Tourette syndrome	0.822	1	CbGaD
Ketamine—SLC6A2—autonomic nervous system—Gilles de la Tourette syndrome	0.00827	0.0828	CbGeAlD
Ketamine—DRD2—Dopamine receptors—DRD3—Gilles de la Tourette syndrome	0.00419	0.0533	CbGpPWpGaD
Ketamine—DRD2—Dopamine receptors—DRD4—Gilles de la Tourette syndrome	0.00406	0.0517	CbGpPWpGaD
Ketamine—GRIN1—midbrain—Gilles de la Tourette syndrome	0.00343	0.0343	CbGeAlD
Ketamine—GRIN2C—nervous system—Gilles de la Tourette syndrome	0.0034	0.0341	CbGeAlD
Ketamine—GRIN2C—central nervous system—Gilles de la Tourette syndrome	0.00327	0.0328	CbGeAlD
Ketamine—GRIN2D—nervous system—Gilles de la Tourette syndrome	0.00316	0.0317	CbGeAlD
Ketamine—GRIN2D—central nervous system—Gilles de la Tourette syndrome	0.00304	0.0305	CbGeAlD
Ketamine—GRIN2C—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.00301	0.0383	CbGpPWpGaD
Ketamine—GRIN3A—nervous system—Gilles de la Tourette syndrome	0.00297	0.0298	CbGeAlD
Ketamine—GRIN3A—central nervous system—Gilles de la Tourette syndrome	0.00286	0.0287	CbGeAlD
Ketamine—GRIN2A—midbrain—Gilles de la Tourette syndrome	0.00286	0.0286	CbGeAlD
Ketamine—GRIN1—nervous system—Gilles de la Tourette syndrome	0.00282	0.0282	CbGeAlD
Ketamine—GRIN2C—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.00281	0.0357	CbGpPWpGaD
Ketamine—GRIN2D—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.0028	0.0356	CbGpPWpGaD
Ketamine—GRIN1—central nervous system—Gilles de la Tourette syndrome	0.00271	0.0272	CbGeAlD
Ketamine—GRIN2B—nervous system—Gilles de la Tourette syndrome	0.00269	0.0269	CbGeAlD
Ketamine—GRIN2D—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.00261	0.0332	CbGpPWpGaD
Ketamine—GRIN2C—brain—Gilles de la Tourette syndrome	0.0026	0.026	CbGeAlD
Ketamine—GRIN2B—central nervous system—Gilles de la Tourette syndrome	0.00259	0.0259	CbGeAlD
Ketamine—TACR1—nervous system—Gilles de la Tourette syndrome	0.00258	0.0258	CbGeAlD
Ketamine—TACR1—central nervous system—Gilles de la Tourette syndrome	0.00248	0.0248	CbGeAlD
Ketamine—GRIN2D—brain—Gilles de la Tourette syndrome	0.00242	0.0242	CbGeAlD
Ketamine—GRIN2A—nervous system—Gilles de la Tourette syndrome	0.00235	0.0235	CbGeAlD
Ketamine—GRIN2A—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.0023	0.0293	CbGpPWpGaD
Ketamine—GRIN3A—brain—Gilles de la Tourette syndrome	0.00227	0.0228	CbGeAlD
Ketamine—GRIN2A—central nervous system—Gilles de la Tourette syndrome	0.00226	0.0227	CbGeAlD
Ketamine—GRIN1—brain—Gilles de la Tourette syndrome	0.00215	0.0216	CbGeAlD
Ketamine—GRIN2A—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.00214	0.0273	CbGpPWpGaD
Ketamine—OPRD1—nervous system—Gilles de la Tourette syndrome	0.00209	0.021	CbGeAlD
Ketamine—GRIN2B—brain—Gilles de la Tourette syndrome	0.00205	0.0206	CbGeAlD
Ketamine—OPRD1—central nervous system—Gilles de la Tourette syndrome	0.00202	0.0202	CbGeAlD
Ketamine—OPRK1—nervous system—Gilles de la Tourette syndrome	0.00201	0.0201	CbGeAlD
Ketamine—GRIN1—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.00201	0.0255	CbGpPWpGaD
Ketamine—TACR1—brain—Gilles de la Tourette syndrome	0.00197	0.0197	CbGeAlD
Ketamine—GRIN2B—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.00196	0.0249	CbGpPWpGaD
Ketamine—OPRK1—central nervous system—Gilles de la Tourette syndrome	0.00193	0.0194	CbGeAlD
Ketamine—OPRD1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00193	0.0246	CbGpPWpGaD
Ketamine—GRIN1—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.00187	0.0238	CbGpPWpGaD
Ketamine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.00186	0.0237	CbGpPWpGaD
Ketamine—GRIN2B—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.00182	0.0232	CbGpPWpGaD
Ketamine—GRIN2A—brain—Gilles de la Tourette syndrome	0.0018	0.018	CbGeAlD
Ketamine—OPRM1—midbrain—Gilles de la Tourette syndrome	0.00174	0.0174	CbGeAlD
Ketamine—OPRK1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00169	0.0216	CbGpPWpGaD
Ketamine—OPRD1—brain—Gilles de la Tourette syndrome	0.0016	0.016	CbGeAlD
Ketamine—OPRK1—brain—Gilles de la Tourette syndrome	0.00153	0.0154	CbGeAlD
Ketamine—OPRM1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00143	0.0182	CbGpPWpGaD
Ketamine—OPRM1—nervous system—Gilles de la Tourette syndrome	0.00143	0.0143	CbGeAlD
Ketamine—OPRM1—central nervous system—Gilles de la Tourette syndrome	0.00138	0.0138	CbGeAlD
Ketamine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.00133	0.0169	CbGpPWpGaD
Ketamine—SLC6A2—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.00129	0.0164	CbGpPWpGaD
Ketamine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.00129	0.0164	CbGpPWpGaD
Ketamine—SLC6A2—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.00123	0.0156	CbGpPWpGaD
Ketamine—DRD2—midbrain—Gilles de la Tourette syndrome	0.00116	0.0116	CbGeAlD
Ketamine—OPRM1—brain—Gilles de la Tourette syndrome	0.00109	0.0109	CbGeAlD
Ketamine—DRD2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00108	0.0138	CbGpPWpGaD
Ketamine—SLC6A2—nervous system—Gilles de la Tourette syndrome	0.00105	0.0105	CbGeAlD
Ketamine—SLC6A2—central nervous system—Gilles de la Tourette syndrome	0.00101	0.0101	CbGeAlD
Ketamine—DRD2—nervous system—Gilles de la Tourette syndrome	0.000953	0.00954	CbGeAlD
Ketamine—DRD2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000925	0.0118	CbGpPWpGaD
Ketamine—DRD2—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.000921	0.0117	CbGpPWpGaD
Ketamine—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000917	0.00919	CbGeAlD
Ketamine—DRD2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.000898	0.0114	CbGpPWpGaD
Ketamine—SLC6A2—brain—Gilles de la Tourette syndrome	0.000799	0.00801	CbGeAlD
Ketamine—DRD2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000778	0.0099	CbGpPWpGaD
Ketamine—CYP2B6—nervous system—Gilles de la Tourette syndrome	0.000771	0.00772	CbGeAlD
Ketamine—DRD2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000755	0.00961	CbGpPWpGaD
Ketamine—CYP2B6—central nervous system—Gilles de la Tourette syndrome	0.000742	0.00743	CbGeAlD
Ketamine—DRD2—brain—Gilles de la Tourette syndrome	0.000728	0.0073	CbGeAlD
Ketamine—PTGS1—nervous system—Gilles de la Tourette syndrome	0.000697	0.00698	CbGeAlD
Ketamine—PTGS1—central nervous system—Gilles de la Tourette syndrome	0.000671	0.00672	CbGeAlD
Ketamine—GRIN2C—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000659	0.00839	CbGpPWpGaD
Ketamine—CYP2C8—brain—Gilles de la Tourette syndrome	0.000657	0.00658	CbGeAlD
Ketamine—GRIN2D—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000613	0.0078	CbGpPWpGaD
Ketamine—CYP2B6—brain—Gilles de la Tourette syndrome	0.000589	0.0059	CbGeAlD
Ketamine—DRD2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000586	0.00746	CbGpPWpGaD
Ketamine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000582	0.00583	CbGeAlD
Ketamine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.00056	0.00561	CbGeAlD
Ketamine—TACR1—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000535	0.0068	CbGpPWpGaD
Ketamine—PTGS1—brain—Gilles de la Tourette syndrome	0.000532	0.00533	CbGeAlD
Ketamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.000505	0.00643	CbGpPWpGaD
Ketamine—GRIN2C—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000505	0.00643	CbGpPWpGaD
Ketamine—GRIN2A—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000503	0.00641	CbGpPWpGaD
Ketamine—ABCB1—midbrain—Gilles de la Tourette syndrome	0.000501	0.00502	CbGeAlD
Ketamine—DRD2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000493	0.00627	CbGpPWpGaD
Ketamine—TACR1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000484	0.00615	CbGpPWpGaD
Ketamine—GRIN2D—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00047	0.00598	CbGpPWpGaD
Ketamine—TACR1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000469	0.00597	CbGpPWpGaD
Ketamine—TACR1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000463	0.00589	CbGpPWpGaD
Ketamine—GRIN1—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000439	0.00559	CbGpPWpGaD
Ketamine—TACR1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000437	0.00557	CbGpPWpGaD
Ketamine—GRIN2B—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000428	0.00545	CbGpPWpGaD
Ketamine—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000414	0.00526	CbGpPWpGaD
Ketamine—ABCB1—nervous system—Gilles de la Tourette syndrome	0.000412	0.00413	CbGeAlD
Ketamine—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.000397	0.00397	CbGeAlD
Ketamine—GRIN2A—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000386	0.00491	CbGpPWpGaD
Ketamine—GRIN1—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000369	0.00469	CbGpPWpGaD
Ketamine—TACR1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000368	0.00469	CbGpPWpGaD
Ketamine—SLC6A2—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.000364	0.00464	CbGpPWpGaD
Ketamine—TACR1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000358	0.00455	CbGpPWpGaD
Ketamine—OPRD1—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000343	0.00436	CbGpPWpGaD
Ketamine—GRIN1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000336	0.00428	CbGpPWpGaD
Ketamine—TACR1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000333	0.00424	CbGpPWpGaD
Ketamine—OPRD1—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000333	0.00423	CbGpPWpGaD
Ketamine—GRIN2B—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000328	0.00417	CbGpPWpGaD
Ketamine—OPRD1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000318	0.00405	CbGpPWpGaD
Ketamine—ABCB1—brain—Gilles de la Tourette syndrome	0.000315	0.00315	CbGeAlD
Ketamine—OPRD1—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00031	0.00394	CbGpPWpGaD
Ketamine—OPRD1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000309	0.00393	CbGpPWpGaD
Ketamine—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000306	0.0039	CbGpPWpGaD
Ketamine—OPRK1—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.0003	0.00382	CbGpPWpGaD
Ketamine—OPRK1—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000292	0.00371	CbGpPWpGaD
Ketamine—OPRD1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000288	0.00366	CbGpPWpGaD
Ketamine—OPRK1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000279	0.00355	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000272	0.00347	CbGpPWpGaD
Ketamine—OPRK1—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000272	0.00346	CbGpPWpGaD
Ketamine—OPRK1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000271	0.00344	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000264	0.00336	CbGpPWpGaD
Ketamine—OPRM1—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000254	0.00323	CbGpPWpGaD
Ketamine—OPRK1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000252	0.00321	CbGpPWpGaD
Ketamine—OPRM1—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000246	0.00314	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000246	0.00313	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000239	0.00304	CbGpPWpGaD
Ketamine—OPRM1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000236	0.003	CbGpPWpGaD
Ketamine—TACR1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000233	0.00297	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000232	0.00295	CbGpPWpGaD
Ketamine—OPRM1—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00023	0.00292	CbGpPWpGaD
Ketamine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00023	0.00292	CbGpPWpGaD
Ketamine—OPRM1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000229	0.00291	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000218	0.00277	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000216	0.00275	CbGpPWpGaD
Ketamine—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000213	0.00271	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000212	0.00269	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000208	0.00265	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000207	0.00264	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000202	0.00257	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000202	0.00257	CbGpPWpGaD
Ketamine—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000201	0.00256	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000201	0.00256	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000196	0.00249	CbGpPWpGaD
Ketamine—DRD2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000192	0.00245	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000189	0.0024	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000188	0.00239	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000188	0.00239	CbGpPWpGaD
Ketamine—DRD2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000187	0.00238	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000183	0.00233	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—MET—Gilles de la Tourette syndrome	0.000183	0.00233	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000183	0.00232	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000182	0.00231	CbGpPWpGaD
Ketamine—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000179	0.00227	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—MET—Gilles de la Tourette syndrome	0.000179	0.00227	CbGpPWpGaD
Ketamine—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000177	0.00225	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000177	0.00225	CbGpPWpGaD
Ketamine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000173	0.00221	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000173	0.0022	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000171	0.00217	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000164	0.00209	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000154	0.00196	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000153	0.00195	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000151	0.00193	CbGpPWpGaD
Ketamine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000149	0.0019	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000149	0.0019	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000149	0.00189	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000139	0.00177	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000132	0.00168	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000131	0.00167	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000131	0.00166	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000128	0.00163	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000127	0.00162	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000123	0.00156	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00012	0.00152	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000117	0.00149	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000117	0.00148	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000116	0.00148	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000115	0.00147	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000114	0.00145	CbGpPWpGaD
Ketamine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000113	0.00144	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000113	0.00144	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000112	0.00142	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000108	0.00138	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000106	0.00135	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000106	0.00135	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000103	0.00131	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000103	0.00131	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000101	0.00128	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	9.98e-05	0.00127	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	9.74e-05	0.00124	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	9.69e-05	0.00123	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	9.63e-05	0.00122	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—HDC—Gilles de la Tourette syndrome	9.38e-05	0.00119	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	9.33e-05	0.00119	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	9.3e-05	0.00118	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	9.06e-05	0.00115	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.69e-05	0.00111	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	8.44e-05	0.00107	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.43e-05	0.00107	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—HDC—Gilles de la Tourette syndrome	7.94e-05	0.00101	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.89e-05	0.001	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.86e-05	0.001	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.66e-05	0.000974	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	7.42e-05	0.000945	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.38e-05	0.000939	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	7.13e-05	0.000908	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.07e-05	0.0009	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	6.91e-05	0.00088	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	6.74e-05	0.000858	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.58e-05	0.000838	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	6.51e-05	0.000828	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—HDC—Gilles de la Tourette syndrome	6.46e-05	0.000822	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.39e-05	0.000813	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	6.29e-05	0.0008	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	6.1e-05	0.000777	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.98e-05	0.000761	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.91e-05	0.000752	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.8e-05	0.000739	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.69e-05	0.000724	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	5.51e-05	0.000702	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.5e-05	0.0007	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	5.35e-05	0.000681	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	5.14e-05	0.000654	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5e-05	0.000636	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.99e-05	0.000635	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.66e-05	0.000593	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.52e-05	0.000576	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	4.26e-05	0.000542	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.21e-05	0.000536	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.17e-05	0.000531	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.98e-05	0.000507	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.79e-05	0.000482	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.53e-05	0.000449	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.49e-05	0.000444	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.43e-05	0.000436	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.95e-05	0.000376	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.24e-05	0.000285	CbGpPWpGaD
